You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Herpes Simplex virus type 2 infection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Suspended
  • HSV-2 Infection
  • Herpes Simplex Virus Infection
  • Diagnostic Test: NOWDx HSV-2 Test
  • Tempe, Arizona
  • +2 more
Sep 29, 2022

Recurrent Genital Herpes Trial (UB-621)

Not yet recruiting
  • Recurrent Genital Herpes
  • UB-621
  • (no location specified)
May 16, 2022

Associated Burden of Related Conditions in Alopecia Areata

Completed
  • Alopecia Areata
  • +35 more
  • Exposure of interest (studies 2 & 3).
  • London, United Kingdom
    Momentum Data Ltd
Dec 13, 2022

Protein Biomarkers in Neonatal Herpes Simplex Virus Infection

Completed
  • Neonatal Herpes Simplex Infection
  • +7 more
    • Copenhagen, Denmark
    • +1 more
    Dec 25, 2022

    HSV Trial (Pritelivir)

    Available
    • HSV
    • (no location specified)
    Apr 25, 2023

    Herpes Simplex-virus Type 1 (HSV-1) Reactivation

    Recruiting
    • Tracheobronchitis
    • Herpes Simplex Infection
    • Patients with herpes-simplex infection requiring bronchoscopy
    • Münster, Germany
      University Hospital Münster
    Apr 11, 2022

    Frequency of Symptomatic Herpes Virus I and II in HIV Infected

    Recruiting
    • HIV Disease
    • +2 more
    • Blood draw
    • Los Angeles, California
      Global Research Institute
    Apr 9, 2023

    Neonatal Herpes Simplex Infection Trial in Birmingham (Valacyclovir)

    Recruiting
    • Neonatal Herpes Simplex Infection
    • Birmingham, Alabama
      University of Alabama - Children's of Alabama
    Sep 12, 2022

    Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)

    Not yet recruiting
    • Genital Herpes Simplex Type 2
    • BNT163
    • Placebo
    • (no location specified)
    Jun 21, 2022

    Pneumonia, Viral, Ventilator Associated Pneumonia, Community-acquired Pneumonia Trial (Acyclovir)

    Not yet recruiting
    • Pneumonia, Viral
    • +4 more
    • (no location specified)
    Nov 16, 2023

    Herpes Labialis Trial in Germany (drug, behavioral, procedure)

    Active, not recruiting
    • Herpes Labialis
    • HDIT101 (blinded therapy)
    • +5 more
    • Berlin, Germany
    • +4 more
    Jan 26, 2023

    Melanoma Trial in Beijing (OH2 injection, HX008 injection)

    Recruiting
    • Melanoma
    • OH2 injection
    • HX008 injection
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Jan 28, 2023

    Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))

    Recruiting
    • Sarcoma
    • +9 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Linyi, Shandong, China
      Linyi Central Hospital
    Jul 25, 2023

    Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))

    Recruiting
    • Sarcoma
    • +8 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Shanghai, Jiangsu, China
      Xuzhou Second People's Hospital
    May 8, 2023

    Cervical Cancer, Endometrial Cancer, Advanced Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type ?

    Recruiting
    • Cervical Cancer
    • +2 more
    • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
    • Shanghai, Shanghai, China
      Shanghai Tenth People's Hospital
    Mar 31, 2023

    Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))

    Recruiting
    • Osteosarcoma
    • +3 more
    • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
    • Xi'an, Shaanxi, China
      Xi'an Honghui Hospital
    May 8, 2023

    Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus

    Recruiting
    • Ovarian Cancer
    • +2 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Shanghai, Shanghai, China
      Shanghai Tenth People's Hospital
    Mar 26, 2023

    Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus

    Recruiting
    • Head and Neck Cancer
    • +6 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Shanghai, China
      Eye & ENT Hospital of Fudan University
    Apr 13, 2023

    Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

    Recruiting
    • Lung Cancer
    • +11 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Anqing, Anhui, China
      The PLA Navy Anqing Hospital
    May 23, 2023

    HSV, Herpes Labialis Trial in Saint Paul (Squaric Acid Dibutyl Ester)

    Completed
    Has Results
    • HSV
    • Herpes Labialis
    • Squaric Acid Dibutyl Ester
    • Saint Paul, Minnesota
      Prism Clinical Research, LLC
    Oct 5, 2021

    Intravenous Acyclovir in Oncologic Paediatric Patients

    Active, not recruiting
    • Herpesviridae Infections
    • +4 more
    • Pharmacokinetic analysis
    • Trieste, TS, Italy
      IRCCS Burlo Garofolo, Bone Marrow Transplant Unit, Institute for
    Jan 19, 2022

    Viral Keratitis, Blindness Eye, Herpes Simplex Virus Infection Trial in Shanghai (BD111 Adult single group Dose)

    Completed
    • Viral Keratitis
    • +3 more
    • BD111 Adult single group Dose
    • Shanghai, Shanghai, China
      Eye & Ent Hospital of Fudan University
    Aug 20, 2022

    Solid Tumor, Melanoma Trial in Beijing (OH2 injection, Keytruda)

    Recruiting
    • Solid Tumor
    • Melanoma
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Apr 1, 2022

    Uterine Cervical Tumors Trial in Wuhan (BS-006)

    Not yet recruiting
    • Uterine Cervical Neoplasms
    • BS-006
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Jun 6, 2022

    Pancreatic Cancer Trial in Chongqing (OH2 injection)

    Recruiting
    • Pancreatic Cancer
    • OH2 injection
    • Chongqing, Chongqing, China
      Chongqing University Cancer Hospital
    Jan 27, 2022